2023-2029 Global Liposomal Drug Delivery System Industry Research & Trends Analysis Report
According to YH Research, the global market for Liposomal Drug Delivery System should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Liposomal Drug Delivery System market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Liposomal Drug Delivery System market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Liposomal Doxorubicin segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Liposomal Drug Delivery System include Johnson & Johnson Services, Inc. (U.S.), Gilead Sciences Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd (Israel), Janssen Pharmaceuticals Inc. (Belgium), CELSION corporation (U.S.）, Abbott (U.S.) and Ipsen Pharma (France), etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Liposomal Drug Delivery System. Report Highlights:
(1) Global Liposomal Drug Delivery System market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Liposomal Drug Delivery System market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Liposomal Drug Delivery System market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Liposomal Drug Delivery System segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Liposomal Drug Delivery System segment by type and by application and regional segment by type and by application.
(6) Liposomal Drug Delivery System industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
Market segment by application, can be divided into
Hospital
Specialty Clinic
Others
Market segment by players, this report covers
Johnson & Johnson Services, Inc. (U.S.)
Gilead Sciences Inc. (U.S.)
Sun Pharmaceutical Industries Ltd. (India)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd (Israel)
Janssen Pharmaceuticals Inc. (Belgium)
CELSION corporation (U.S.）
Abbott (U.S.)
Ipsen Pharma (France)
Spectrum Pharmaceuticals, Inc. (U.S.)
Takeda Pharmaceutical Company Limited. (Japan)
1 Market Overview
1.1 Product Overview and Scope of Liposomal Drug Delivery System
1.2 Global Liposomal Drug Delivery System Market Size and Forecast
1.3 China Liposomal Drug Delivery System Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Liposomal Drug Delivery System Share in Global Market, 2018-2029
1.4.2 Liposomal Drug Delivery System Market Size: China VS Global, 2018-2029
1.5 Liposomal Drug Delivery System Market Dynamics
1.5.1 Liposomal Drug Delivery System Market Drivers
1.5.2 Liposomal Drug Delivery System Market Restraints
1.5.3 Liposomal Drug Delivery System Industry Trends
1.5.4 Liposomal Drug Delivery System Industry Policy
2 Global Competitive Situation by Company
2.1 Global Liposomal Drug Delivery System Revenue by Company (2018-2023)
2.2 Global Liposomal Drug Delivery System Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Liposomal Drug Delivery System Concentration Ratio
2.4 Global Liposomal Drug Delivery System Mergers & Acquisitions, Expansion Plans
2.5 Global Liposomal Drug Delivery System Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Liposomal Drug Delivery System Revenue by Company (2018-2023)
3.2 China Liposomal Drug Delivery System Liposomal Drug Delivery System Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Liposomal Drug Delivery System, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Liposomal Drug Delivery System Industry Chain
4.2 Liposomal Drug Delivery System Upstream Analysis
4.3 Liposomal Drug Delivery System Midstream Analysis
4.4 Liposomal Drug Delivery System Downstream Analysis
5 Sights by Type
5.1 Liposomal Drug Delivery System Classification
5.1.1 Liposomal Doxorubicin
5.1.2 Liposomal Paclitaxel
5.1.3 Liposomal Amphotericin B
5.1.4 Others
5.2 By Type, Global Liposomal Drug Delivery System Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Liposomal Drug Delivery System Revenue, 2018-2029
6 Sights by Application
6.1 Liposomal Drug Delivery System Segment by Application
6.1.1 Hospital
6.1.2 Specialty Clinic
6.1.3 Others
6.2 By Application, Global Liposomal Drug Delivery System Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Liposomal Drug Delivery System Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Liposomal Drug Delivery System Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Liposomal Drug Delivery System Market Size, 2018-2029
7.3 North America
7.3.1 North America Liposomal Drug Delivery System Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Liposomal Drug Delivery System Market Size Market Share
7.4 Europe
7.4.1 Europe Liposomal Drug Delivery System Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Liposomal Drug Delivery System Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Liposomal Drug Delivery System Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Liposomal Drug Delivery System Market Size Market Share
7.6 South America
7.6.1 South America Liposomal Drug Delivery System Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Liposomal Drug Delivery System Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Liposomal Drug Delivery System Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Liposomal Drug Delivery System Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Liposomal Drug Delivery System Market Size, 2018-2029
8.3.2 By Company, U.S. Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Liposomal Drug Delivery System Market Size, 2018-2029
8.4.2 By Company, Europe Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Liposomal Drug Delivery System Market Size, 2018-2029
8.5.2 By Company, China Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.5.3 By Type, China Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Liposomal Drug Delivery System Market Size, 2018-2029
8.6.2 By Company, Japan Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Liposomal Drug Delivery System Market Size, 2018-2029
8.7.2 By Company, South Korea Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Liposomal Drug Delivery System Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Liposomal Drug Delivery System Market Size, 2018-2029
8.9.2 By Company, India Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.9.3 By Type, India Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Liposomal Drug Delivery System Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Johnson & Johnson Services, Inc. (U.S.)
9.1.1 Johnson & Johnson Services, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
9.1.2 Johnson & Johnson Services, Inc. (U.S.) Company Profile and Main Business
9.1.3 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.1.4 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.1.5 Johnson & Johnson Services, Inc. (U.S.) Recent Developments
9.2 Gilead Sciences Inc. (U.S.)
9.2.1 Gilead Sciences Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
9.2.2 Gilead Sciences Inc. (U.S.) Company Profile and Main Business
9.2.3 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.2.4 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.2.5 Gilead Sciences Inc. (U.S.) Recent Developments
9.3 Sun Pharmaceutical Industries Ltd. (India)
9.3.1 Sun Pharmaceutical Industries Ltd. (India) Company Information, Head Office, Market Area and Industry Position
9.3.2 Sun Pharmaceutical Industries Ltd. (India) Company Profile and Main Business
9.3.3 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Models, Specifications and Application
9.3.4 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.3.5 Sun Pharmaceutical Industries Ltd. (India) Recent Developments
9.4 Novartis AG (Switzerland)
9.4.1 Novartis AG (Switzerland) Company Information, Head Office, Market Area and Industry Position
9.4.2 Novartis AG (Switzerland) Company Profile and Main Business
9.4.3 Novartis AG (Switzerland) Liposomal Drug Delivery System Models, Specifications and Application
9.4.4 Novartis AG (Switzerland) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.4.5 Novartis AG (Switzerland) Recent Developments
9.5 Teva Pharmaceutical Industries Ltd (Israel)
9.5.1 Teva Pharmaceutical Industries Ltd (Israel) Company Information, Head Office, Market Area and Industry Position
9.5.2 Teva Pharmaceutical Industries Ltd (Israel) Company Profile and Main Business
9.5.3 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Models, Specifications and Application
9.5.4 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.5.5 Teva Pharmaceutical Industries Ltd (Israel) Recent Developments
9.6 Janssen Pharmaceuticals Inc. (Belgium)
9.6.1 Janssen Pharmaceuticals Inc. (Belgium) Company Information, Head Office, Market Area and Industry Position
9.6.2 Janssen Pharmaceuticals Inc. (Belgium) Company Profile and Main Business
9.6.3 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Models, Specifications and Application
9.6.4 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.6.5 Janssen Pharmaceuticals Inc. (Belgium) Recent Developments
9.7 CELSION corporation (U.S.）
9.7.1 CELSION corporation (U.S.） Company Information, Head Office, Market Area and Industry Position
9.7.2 CELSION corporation (U.S.） Company Profile and Main Business
9.7.3 CELSION corporation (U.S.） Liposomal Drug Delivery System Models, Specifications and Application
9.7.4 CELSION corporation (U.S.） Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.7.5 CELSION corporation (U.S.） Recent Developments
9.8 Abbott (U.S.)
9.8.1 Abbott (U.S.) Company Information, Head Office, Market Area and Industry Position
9.8.2 Abbott (U.S.) Company Profile and Main Business
9.8.3 Abbott (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.8.4 Abbott (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.8.5 Abbott (U.S.) Recent Developments
9.9 Ipsen Pharma (France)
9.9.1 Ipsen Pharma (France) Company Information, Head Office, Market Area and Industry Position
9.9.2 Ipsen Pharma (France) Company Profile and Main Business
9.9.3 Ipsen Pharma (France) Liposomal Drug Delivery System Models, Specifications and Application
9.9.4 Ipsen Pharma (France) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.9.5 Ipsen Pharma (France) Recent Developments
9.10 Spectrum Pharmaceuticals, Inc. (U.S.)
9.10.1 Spectrum Pharmaceuticals, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
9.10.2 Spectrum Pharmaceuticals, Inc. (U.S.) Company Profile and Main Business
9.10.3 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.10.4 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.10.5 Spectrum Pharmaceuticals, Inc. (U.S.) Recent Developments
9.11 Takeda Pharmaceutical Company Limited. (Japan)
9.11.1 Takeda Pharmaceutical Company Limited. (Japan) Company Information, Head Office, Market Area and Industry Position
9.11.2 Takeda Pharmaceutical Company Limited. (Japan) Company Profile and Main Business
9.11.3 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Models, Specifications and Application
9.11.4 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
9.11.5 Takeda Pharmaceutical Company Limited. (Japan) Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Liposomal Drug Delivery System Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Liposomal Drug Delivery System Market Restraints
Table 3. Liposomal Drug Delivery System Market Trends
Table 4. Liposomal Drug Delivery System Industry Policy
Table 5. Global Liposomal Drug Delivery System Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Liposomal Drug Delivery System Revenue Market Share by Company (2018-2023)
Table 7. Global Liposomal Drug Delivery System Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Liposomal Drug Delivery System Mergers & Acquisitions, Expansion Plans
Table 9. Global Liposomal Drug Delivery System Manufacturers Product Type
Table 10. China Liposomal Drug Delivery System Revenue by Company (2018-2023) & (US$ million)
Table 11. China Liposomal Drug Delivery System Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Liposomal Drug Delivery System Upstream (Raw Materials)
Table 13. Global Liposomal Drug Delivery System Typical Customers
Table 14. Liposomal Drug Delivery System Typical Distributors
Table 15. By Type, Global Liposomal Drug Delivery System Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Liposomal Drug Delivery System Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Liposomal Drug Delivery System Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Liposomal Drug Delivery System Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Liposomal Drug Delivery System Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Liposomal Drug Delivery System Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Liposomal Drug Delivery System Revenue Market Share, 2018-2029
Table 22. Johnson & Johnson Services, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
Table 23. Johnson & Johnson Services, Inc. (U.S.) Company Profile and Main Business
Table 24. Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
Table 25. Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 26. Johnson & Johnson Services, Inc. (U.S.) Recent Developments
Table 27. Gilead Sciences Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
Table 28. Gilead Sciences Inc. (U.S.) Company Profile and Main Business
Table 29. Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
Table 30. Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 31. Gilead Sciences Inc. (U.S.) Recent Developments
Table 32. Sun Pharmaceutical Industries Ltd. (India) Company Information, Head Office, Market Area and Industry Position
Table 33. Sun Pharmaceutical Industries Ltd. (India) Company Profile and Main Business
Table 34. Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Models, Specifications and Application
Table 35. Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 36. Sun Pharmaceutical Industries Ltd. (India) Recent Developments
Table 37. Novartis AG (Switzerland) Company Information, Head Office, Market Area and Industry Position
Table 38. Novartis AG (Switzerland) Company Profile and Main Business
Table 39. Novartis AG (Switzerland) Liposomal Drug Delivery System Models, Specifications and Application
Table 40. Novartis AG (Switzerland) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 41. Novartis AG (Switzerland) Recent Developments
Table 42. Teva Pharmaceutical Industries Ltd (Israel) Company Information, Head Office, Market Area and Industry Position
Table 43. Teva Pharmaceutical Industries Ltd (Israel) Company Profile and Main Business
Table 44. Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Models, Specifications and Application
Table 45. Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 46. Teva Pharmaceutical Industries Ltd (Israel) Recent Developments
Table 47. Janssen Pharmaceuticals Inc. (Belgium) Company Information, Head Office, Market Area and Industry Position
Table 48. Janssen Pharmaceuticals Inc. (Belgium) Company Profile and Main Business
Table 49. Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Models, Specifications and Application
Table 50. Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 51. Janssen Pharmaceuticals Inc. (Belgium) Recent Developments
Table 52. CELSION corporation (U.S.） Company Information, Head Office, Market Area and Industry Position
Table 53. CELSION corporation (U.S.） Company Profile and Main Business
Table 54. CELSION corporation (U.S.） Liposomal Drug Delivery System Models, Specifications and Application
Table 55. CELSION corporation (U.S.） Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 56. CELSION corporation (U.S.） Recent Developments
Table 57. Abbott (U.S.) Company Information, Head Office, Market Area and Industry Position
Table 58. Abbott (U.S.) Company Profile and Main Business
Table 59. Abbott (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
Table 60. Abbott (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 61. Abbott (U.S.) Recent Developments
Table 62. Ipsen Pharma (France) Company Information, Head Office, Market Area and Industry Position
Table 63. Ipsen Pharma (France) Company Profile and Main Business
Table 64. Ipsen Pharma (France) Liposomal Drug Delivery System Models, Specifications and Application
Table 65. Ipsen Pharma (France) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 66. Ipsen Pharma (France) Recent Developments
Table 67. Spectrum Pharmaceuticals, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
Table 68. Spectrum Pharmaceuticals, Inc. (U.S.) Company Profile and Main Business
Table 69. Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
Table 70. Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 71. Spectrum Pharmaceuticals, Inc. (U.S.) Recent Developments
Table 72. Takeda Pharmaceutical Company Limited. (Japan) Company Information, Head Office, Market Area and Industry Position
Table 73. Takeda Pharmaceutical Company Limited. (Japan) Company Profile and Main Business
Table 74. Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Models, Specifications and Application
Table 75. Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Revenue and Gross Margin, 2018-2023
Table 76. Takeda Pharmaceutical Company Limited. (Japan) Recent Developments
List of Figure
Figure 1. Liposomal Drug Delivery System Picture
Figure 2. Global Liposomal Drug Delivery System Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Liposomal Drug Delivery System Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Liposomal Drug Delivery System Market Share of Global
Figure 5. Global Liposomal Drug Delivery System Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Liposomal Drug Delivery System Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Liposomal Drug Delivery System Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Liposomal Drug Delivery System Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Liposomal Drug Delivery System Industry Chain
Figure 10. Liposomal Doxorubicin
Figure 11. Liposomal Paclitaxel
Figure 12. Liposomal Amphotericin B
Figure 13. Others
Figure 14. By Type, Global Liposomal Drug Delivery System Revenue, 2018-2029, US$ Million
Figure 15. By Type, Global Liposomal Drug Delivery System Revenue Market Share, 2018-2029
Figure 16. Hospital
Figure 17. Specialty Clinic
Figure 18. Others
Figure 19. By Application, Global Liposomal Drug Delivery System Revenue, 2018-2029, US$ Million
Figure 20. By Application, Global Liposomal Drug Delivery System Revenue Market Share, 2018-2029
Figure 21. By Region, Global Liposomal Drug Delivery System Revenue Market Share, 2018-2029
Figure 22. North America Liposomal Drug Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Liposomal Drug Delivery System Revenue Market Share, 2018-2023
Figure 24. Europe Liposomal Drug Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Liposomal Drug Delivery System Revenue Market Share, 2018-2023
Figure 26. Asia Pacific Liposomal Drug Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Liposomal Drug Delivery System Revenue Market Share, 2018-2023
Figure 28. South America Liposomal Drug Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Liposomal Drug Delivery System Revenue Market Share, 2018-2023
Figure 30. Middle East & Africa Liposomal Drug Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 32. By Company, U.S. Liposomal Drug Delivery System Market Share, 2018-2023
Figure 33. By Type, U.S. Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 34. By Application, U.S. Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 35. Europe Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 36. By Company, Europe Liposomal Drug Delivery System Market Share, 2018-2023
Figure 37. By Type, Europe Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 38. By Application, Europe Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 39. China Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 40. By Company, China Liposomal Drug Delivery System Market Share, 2018-2023
Figure 41. By Type, China Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 42. By Application, China Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 43. Japan Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 44. By Company, Japan Liposomal Drug Delivery System Market Share, 2018-2023
Figure 45. By Type, Japan Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 46. By Application, Japan Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 47. South Korea Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 48. By Company, South Korea Liposomal Drug Delivery System Market Share, 2018-2023
Figure 49. By Type, South Korea Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 50. By Application, South Korea Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 51. Southeast Asia Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 52. By Company, Southeast Asia Liposomal Drug Delivery System Market Share, 2018-2023
Figure 53. By Type, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 54. By Application, Southeast Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 55. India Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 56. By Company, India Liposomal Drug Delivery System Market Share, 2018-2023
Figure 57. By Type, India Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 58. By Application, India Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 59. Middle East & Asia Liposomal Drug Delivery System Revenue, 2018-2029, (US$ Million)
Figure 60. By Company, Middle East & Asia Liposomal Drug Delivery System Market Share, 2018-2023
Figure 61. By Type, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 62. By Application, Middle East & Asia Liposomal Drug Delivery System Revenue Market Share, 2022 VS 2029
Figure 63. Research Methodology
Figure 64. Breakdown of Primary Interviews
Figure 65. Bottom-up Approaches
Figure 66. Top-down Approaches
Reason to Buy
- Current and future of Uncategorized Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Uncategorized Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets